Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working GroupAntonio Palumbo, Philippe Moreau, Hervé Avet‐Loiseau et al.|Journal of Clinical Oncology|2015Cited by 2.2k
Prevention of thalidomide- and lenalidomide-associated thrombosis in myelomaAntonio Palumbo, Jean‐Luc Harousseau, Jeffrey A. Zonder et al.|Leukemia|2007Cited by 839
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group studyShaji Kumar, J H Lee, Juan José Lahuerta et al.|Leukemia|2011Cited by 721
Randomized Phase III Study of Pegylated Liposomal Doxorubicin Plus Bortezomib Compared With Bortezomib Alone in Relapsed or Refractory Multiple Myeloma: Combination Therapy Improves Time to ProgressionRobert Z. Orlowski, Jean‐Luc Harousseau|Journal of Clinical Oncology|2007Cited by 645
Triplet Therapy, Transplantation, and Maintenance until Progression in MyelomaPaul G. Richardson, Irene M. Ghobrial, Susanna Jacobus et al.|New England Journal of Medicine|2022Cited by 457